Skip to content
Menu

Aytu BioPharma Q1 EPS $(0.20) Beats $(0.26) Estimate, Sales $14.842M Beat $13.271M Estimate

Benzinga Newsdesk 1 day ago

NewsEarningsEarnings Beats

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Aytu BioPharma (NASDAQ:AYTU) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(0.26) by 23.08 percent. This is a 150 percent decrease over losses of $(0.08) per share from the

Aytu BioPharma (NASDAQ:AYTU) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(0.26) by 23.08 percent. This is a 150 percent decrease over losses of $(0.08) per share from the same period last year. The company reported quarterly sales of $14.842 million which beat the analyst consensus estimate of $13.271 million by 11.84 percent. This is a 6.78 percent increase over sales of $13.900 million the same period last year.

Read at benzinga.com